Other small molecule inhibitors of c-KIT, such as Selinexor, Regorafenib, and Cabozantinib, have shown mixed results in different soft tissue sarcomas [56,57,58] (Table S3). The gene discussed is KIT; the disease is soft tissue sarcoma.